Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Octopus Biosafety's annualizedNet Income for the quarter that ended in Dec. 2024 was €-0.66 Mil. Octopus Biosafety's average total tangible assets for the quarter that ended in Dec. 2024 was €0.54 Mil. Therefore, Octopus Biosafety's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was -121.59%.
The historical rank and industry rank for Octopus Biosafety's Return-on-Tangible-Asset or its related term are showing as below:
STU:OCR'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -377.6 Med: -69.22 Max: 4.12
Current: -121.59
During the past 10 years, Octopus Biosafety's highest Return-on-Tangible-Asset was 4.12%. The lowest was -377.60%. And the median was -69.22%.
STU:OCR's Return-on-Tangible-Asset is ranked worse than 98.24% of 2501
companies
in the Hardware industry
Industry Median: 2.44
vs STU:OCR: -121.59
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Octopus Biosafety Return-on-Tangible-Asset Related Terms
Octopus Biosafety Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:OCR vs DELL, ANET, SNDK: Return-on-Tangible-Asset Comparison
For the Computer Hardware subindustry, Octopus Biosafety's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety Return-on-Tangible-Asset vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Dec. 2024) net income data.
What does a Return-on-Tangible-Asset of -121.59% mean?
Octopus Biosafety (STU:OCR) has a Return-on-Tangible-Asset of -121.59% as of Dec. 2024. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Octopus Biosafety and its competitors. According to the industry distribution chart, Octopus Biosafety ranks #2457 out of 2501 companies in the Hardware industry, placing it in the top 98.2%.
Is Octopus Biosafety's Return-on-Tangible-Asset too high?
Octopus Biosafety's current Return-on-Tangible-Asset is -121.59%. Based on the distribution chart, Octopus Biosafety ranks #2457 out of 2501 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Octopus Biosafety has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Return-on-Tangible-Asset compare to DELL and ANET?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #2457 out of 2501 companies for Return-on-Tangible-Asset. This places Octopus Biosafety in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Hardware company?
The median Return-on-Tangible-Asset among Hardware companies is 2.44, based on 2,501 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median Return-on-Tangible-Asset is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current Return-on-Tangible-Asset is -121.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Return-on-Tangible-Asset of -121.59%. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Return-on-Tangible-Asset is -121.59%. Octopus Biosafety's overall GF Score™ is 1/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Return-on-Tangible-Asset is -121.59% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (STU:OCR) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued.
The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.
Key valuation signals for STU:OCR:
Return-on-Tangible-Asset: -121.59%
GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
1GF Score
Get the complete analysis for STU:OCR
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
